Multinational evaluation of the efficacy and safety of once-weekly peginterferon alfa 2a (PEG-IFN) in patients with chronic hepatitis C (CHC) with compensated cirrhosis [Abstract # 621] - Heathcote,E.; Shiffman,M.; Cooksley,G. (Hepatology, 1999)